Pregnancy and Female Reproductive Disorders
Positive socioeconomic and cultural changes, as well as medical advances, have resulted in increased life expectancy and quality of life for women, particularly in their reproductive years. Gender differences in mortality, life expectancy and to a lesser extent for health expectancy is well known internationally. External preventable causes of death, such as smoking and injuries, were responsible for a significant portion of the gender gap in mortality previously. The life expectancy presently is reported to be 79 years in women and 74 years in men in the US with other developed countries’ life expectancy being quite similar. A larger death burden is observed in women for sex-specific causes of death. Women’s risk for many diseases increases at menopause, which occurs at a median age of 51.4 years. In industrialized countries, women spend 30% of their lifetime in the postmenopausal period. Menopause is associated with a number of significant physiologic and metabolic changes, in that rate of cardiovascular disease increase and bone density decreases.
KeywordsObesity Hepatitis Estrogen Nicotine Estradiol
Wizeman TM, Pardue ML (eds): Exploring the Biological Contributions to Human Health: Does Sex Matter?
Washington DC, National Academy of Sciences, 2001.Google Scholar
Koonin LM et al.
Pregnancy-related mortality surveillance — United States, 1987–1990. MMWR CDC Surveill Summ
. 1997; 46(4): 17–36.Google Scholar
Nybo Andersen AM et al.
Maternal age and fetal loss: population based register linkage study. BMJ
Weiss JL et al.
Obesity, obstetric complications and cesarean delivery rate — a populations-based screening study. Am J Obstet Gynecol
2004; 190(4): 1091–7.CrossRefGoogle Scholar
Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res
2004; 6(Supp 2):S125–40.CrossRefGoogle Scholar
Roberts JM et al.
Summary of the NHLBI Working Group on research on hypertension in pregnancy. Hypertens Pregnancy
2003; 22(2): 109–27.CrossRefGoogle Scholar
Zhang J et al.
Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy
2003; 22(2): 203–12.CrossRefGoogle Scholar
Ben-Haroush A et al.
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med
2004; 21(2): 103–13.CrossRefGoogle Scholar
Xiong X et al
Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet
2001; 75(3): 221–8.CrossRefGoogle Scholar
Evers IM et al.
Risk of complications of pregnancy in women with type 1 diabetes nationwide prospective study in the Netherlands. BMJ
2004; 328(7445): 915. Epub 2004 Apr 05.CrossRefGoogle Scholar
Lange SS, Jenner M. Myocardial infarction in the obstetric patient. Grit Gare Nurs Clin North Am
2004; 16(2): 211–9.CrossRefGoogle Scholar
Su GL, Van Dyke RW. Pregnancy-related liver diseases. Gurr Treatment Options in Gastroent
2000; 3: 501–8.CrossRefGoogle Scholar
Kumar A et al.
Hepatitis E in pregnancy. Int J Gynaecol Obstet
2004 Jun; 85(3): 240–4.CrossRefGoogle Scholar
Rugo HS. Management of breast cancer diagnosed during pregnancy. Gurr Treat Options Oncol
2003; 4(2): 165–73.CrossRefGoogle Scholar
Le J et al.
Urinary tract infections during pregnancy. Ann Pharmacother
2004; 38(10): 1692–701.CrossRefGoogle Scholar
Anderson FW et al.
Sudden death: ectopic pregnancy mortality. Obstet Gynecol
2004; 103(6): 1218–23.CrossRefGoogle Scholar
Venn A et al.
Mortality in a cohort of IVF patients. Hum Reprod
2001; 16(12): 2691–6.CrossRefGoogle Scholar
Jackson RA et al.
Perinatal outcomes in singletons following in vitro fertilization: meta-analysis. Obstet Gynecol
2004; 103(3): 551–63.CrossRefGoogle Scholar
Blickstein I, Keith LG. Outcome of triplets and high-order multiple pregnancies. Gurr Opin Obstet Gynecol
2003; 15(2): 113–7.CrossRefGoogle Scholar
Miller WC et al.
Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA
2004; 291(18): 2229–36.CrossRefGoogle Scholar
Marshall K. Polycystic ovary syndrome: clinical considerations. Altern Med Rev
2001: 6(3): 272–92.Google Scholar
Norman RJ. Obesity, polycystic ovary syndrome and anovulation — how are they interrelated. Obstet Gynec
2001: 13(3): 323.Google Scholar
Modesitt SC et al.
Ovarian and extraovarian endo-metriosis-associated cancer. Obstet Gynecol
. 2002; 100(4): 788–95.CrossRefGoogle Scholar
Koshiyama M et al.
The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri. Cancer Detect Prev
2004; 28(2): 94–8.CrossRefGoogle Scholar
Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol
2004; 104(2): 393–406.CrossRefGoogle Scholar
International Statistical Classification of Diseases and Related Health Problems
, 1989 revision. Geneva: World Health Organization; 1992.Google Scholar
Davis AJ, Johnson SR. Premenstrual syndrome
. American College of Obstetricians and Gynecologists Practice Bulletin, No. 15. Washington DC: American College of Obstetricians and Gynecologists: 2000.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders
, 4th edn. Washington DC: American Psychiatric Association; 1994Google Scholar
Borenstein JE et al.
Health and economic impact of the premenstrual syndrome. J Reprod Med
2003; 48: 515–524.Google Scholar
Pike MC et al.
Prevention of cancers of the breast, endometrium, and ovary. Oncogene
2004; 23(38): 6379–91.CrossRefGoogle Scholar
Althuis MD et al.
Breast cancers among very young premenopausal women (United States). Cancer Causes and Control
2003: 14(2): 151–60.CrossRefGoogle Scholar
Narod SA et al.
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. NEJM
1998; 339(7): 424–28.CrossRefGoogle Scholar
Smith JS et al.
Cervical cancer and use or hormonal contraceptives: a systemic review. Lancet
2003; 361(9364): 1159–67.CrossRefGoogle Scholar
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA
. 2002; 288: 321–333CrossRefGoogle Scholar
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative Randomized Controlled Trial. JAMA
2004; 291(14): 1701–12.CrossRefGoogle Scholar
Nelson HD et al.
Postmenopausal hormone replacement therapy: scientific review. JAMA
2002; 288(7): 872–81.CrossRefGoogle Scholar
Margolis KL et al.
Women’s Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. JAMA
2004; 291: 2959–68.CrossRefGoogle Scholar
Beral V. Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet
2003; 362(9382): 419–27.CrossRefGoogle Scholar
© Palgrave Macmillan, a division of Macmillan Publishers Limited 2006